Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases

Reports on vaccine immunogenicity in patients with systemic autoimmune rheumatic diseases (SARDs) have been inconclusive. Here, we report the immunogenicity of heterologous prime-boost with an inactivated vaccine followed by an adenoviral vector vaccine in patients with SARDs using anti-RBD antibodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Intapiboon, Porntip, Uae-areewongsa, Parichat, Ongarj, Jomkwan, Sophonmanee, Ratchanon, Seepathomnarong, Purilap, Seeyankem, Bunya, Surasombatpattana, Smonrapat, Pinpathomrat, Nawamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666508/
https://www.ncbi.nlm.nih.gov/pubmed/36379939
http://dx.doi.org/10.1038/s41541-022-00568-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666508/
https://www.ncbi.nlm.nih.gov/pubmed/36379939
http://dx.doi.org/10.1038/s41541-022-00568-9

Ejemplares similares